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Takaishi S, Shibata W, Tomita H, Jin G, Yang X, Ericksen R,
Dubeykovskaya Z, Asfaha S, Quante M, Betz KS, Shulkes A,
Wang TC. In vivo analysis of mouse gastrin gene regulation in
enhanced GFP-BAC transgenic mice. Am J Physiol Gastrointest Liver
Physiol 300: G334 –G344, 2011. First published November 4, 2010;
doi:10.1152/ajpgi.00134.2010.—Gastrin is secreted from a subset of
neuroendocrine cells residing in the gastric antrum known as G cells,
but low levels are also expressed in fetal pancreas and intestine and in
many solid malignancies. Although past studies have suggested that
antral gastrin is transcriptionally regulated by inflammation, gastric
pH, somatostatin, and neoplastic transformation, the transcriptional
regulation of gastrin has not previously been demonstrated in vivo.
Here, we describe the creation of an enhanced green fluorescent
protein reporter (mGAS-EGFP) mouse using a bacterial artificial
chromosome that contains the entire mouse gastrin gene. Three
founder lines expressed GFP signals in the gastric antrum and the
transitional zone to the corpus. In addition, GFP(⫹) cells could be
detected in the fetal pancreatic islets and small intestinal villi, but not
in these organs of the adult mice. The administration of acid-suppressive reagents such as proton pump inhibitor omeprazole and gastrin/
CCK-2 receptor antagonist YF476 significantly increased GFP signal
intensity and GFP(⫹) cell numbers in the antrum, whereas these
parameters were decreased by overnight fasting, octreotide (longlasting somatostatin ortholog) infusion, and Helicobacter felis infection. GFP(⫹) cells were also detected in the anterior lobe of the
pituitary gland and importantly in the colonic tumor cells induced by
administration with azoxymethane and dextran sulfate sodium salt.
This transgenic mouse provides a useful tool to study the regulation of
mouse gastrin gene in vivo, thus contributing to our understanding of
the mechanisms involved in transcriptional control of the gastrin gene.
BAC transgenic; mouse gastrin gene; EGFP; G cells

hormone secreted from neuroendocrine cells termed “G cells” located in the antrum and the
transitional zone to the corpus of the adult stomach (11).
Gastrin has been identified as the circulating hormone primarily responsible for stimulation of acid secretion from the
stomach. Gastrin is also a potent growth factor that has been
implicated in a variety of normal and abnormal biological
processes including maintenance of the gastric mucosa, proliferation of enterochromaffin-like (ECL) cells, and neoplastic
transformation (28). Gastrin gene and protein expression in G
cells is regulated by changes in gastric pH, fasting, and refeeding (41), and gastrin expression is suppressed by somatostatin,
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another gastrointestinal hormone secreted from neuroendocrine “D cells” located adjacent to G cells in the adult gastric
antrum (11). Chronic gastritis caused by Helicobacter pylori
(H. pylori) infection in the stomach also modulates gastrin
expression (14, 35) and over time possibly suppresses G cell
numbers (11). Studies in the past have clearly demonstrated
that induction of achlorhydria by proton pump inhibitors results in elevations in both serum gastrin as well as antral gastrin
mRNA levels (3). In addition, it was reported that gastrin gene
expression was upregulated by oncogenic K-Ras mutation,
abnormal Wnt/␤-catenin stimulation, and activated TGF-␤/
Smad signals in the colon cancer cells (6, 17, 21, 25).
However, whether these changes in gene expression are due
to transcriptional control or to other mechanisms has been
difficult to specifically address. Thus, although administration
to rodents of the proton pump inhibitor omeprazole can induce
a fourfold increase in gastrin mRNA (3), the increase could in
theory be due entirely to alterations in mRNA stability or
turnover. The mechanisms involved in the transcriptional regulation of mammalian antral gastrin gene expression have been
challenging to study in vitro because of the absence of G cell
lines and in vivo because of the lack of appropriate transgenic
models. In addition, although numerous reports have suggested
that gastrin is upregulated in colon, liver, pancreatic, lung, and
ovarian cancer (1, 4, 5, 8, 18, 39), studies of cell-specific
expression of gastrin in the setting of neoplasia have been
limited.
We and other groups previously reported that the use of rat
and human gastrin gene promoters are able to drive the expression of human gastrin and other cDNAs in mice (24, 41,
43, 46), but to date none of these have been able to achieve
authentic cell-specific expression in both of a tissue-specific
and developmental-specific manner. In particular, with respect
to antral G cell expression, some success has been achieved
with a chimeric rat-human transgene that contained most of
human gastrin intron I and all of intron II (41). Human gastrin
promoters, of lengths less than 3 kb, resulted consistently in no
detectable antral G cell expression (41), whereas 10.5 kb of
human gastrin transgene (5 kb of 5= flanking DNA, 4 kb of the
entire transcribed region, and 1.5 kb of 3= flanking sequence)
was used to drive SV40 T antigen expression and resulted in
antral hyperplasia of gastrin-expressing cells (24). These results supported the notion that tissue-specific expression of the
gastrin promoter in the stomach may require enhancers presented in 5=, 3=, and intragenic region. More recently, a
transgenic mouse containing a human gastrin BAC clone
(hGasBAC) was generated and crossed to gastrin-deficient
(GAS-KO) mouse (23). This double-mutant mouse success-
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fully expressed human gastrin in G cells of the gastric antrum,
but interestingly no gastrin was detected in the serum, suggesting some species differences in gastrin exportation and secretion.
The use of reporter genes such as GFP has been of great
value for both tracking gene expression in vivo as well as for
studies of transcriptional regulation. Green fluorescent protein
(GFP) was originally discovered in the marine jellyfish Aequorea victoria as a side product after purification of aequorin,
a chemiluminescent protein, from which emission of blue light
leads to excitation of its companion protein GFP, thereby
resulting in green fluorescence, and the enhanced version of
GFP (EGFP) is now widely used in the biochemical studies (7,
32, 38). In view of the fact that prior gastrin-promoter transgene constructs were unable to completely recapitulate the
native tissue specific expression pattern of the mouse gastrin
gene in both adult and fetal tissues, we created a transgenic
reporter mouse that expresses EGFP using a bacterial artificial
chromosome (BAC) (9, 34). Moreover, we demonstrate that
pharmacological stimulation as well as pathophysiological
conditions regulates the transcription of the mouse gastrin gene
by tracing GFP signals. We demonstrate in this study that the
mouse gastrin gene is regulated in the stomach in a transcriptional manner by physiological stimuli and that the gene is
transcriptionally upregulated in the setting of cancer.
MATERIALS AND METHODS

Creation of BAC transgene construct and mGAS-EGFP reporter
mouse. The Ensemble 129S7-derived mouse genomic BAC clone
bMQ262-F1, which contains the entire mouse gastrin gene, was
obtained from the Genome Research Limited, the Wellcome Trust
Sanger Institute (Cambridge, UK). The open reading frame of the
mouse gastrin gene after ATG start codon located in exon 2 and 3 was
then replaced by the EGFP-PGK-neomycin cassette by the recombineering-base cloning strategy (9). The PGK-neomycin cassette was
removed by arabinose-induced Flpe recombinase gene. The fertilized
eggs of B6/CBAF1 hybrid mice were injected with the BAC transgenic construct and transplanted into pseudo-pregnant mothers. Potential F0 founders were genotyped by tail DNA PCR using following
two different primer pairs: 1) universal EGFP primers: sense 5==gagctgaagggcatcgacttcaag-3=, antisense 5=-ggactgggtgctcaggtagtgg-3=
and 2) transgene-specific primers: sense 5=-ttagtgtgcgcatgcctctttgtt-3=,
antisense 5=-cagctcctcgcccttgctca-3=. PCR amplification was performed by GeneAmp PCR System 2700 (Applied Biosystems) by
using a PCR core kit (Roche) with the following conditions: 94°C for
2 min, followed by 35 cycles at 94°C for 30 s, 55°C for 30 s, and 72°C
for 30 s, then 1 cycle of 72°C for 7 min. Three positive founders were
obtained, and the offspring of these three lines were bred to congenic
C57/BL6NTac mice (Taconic) in five generations to maintain the
transgene.
Animal care and Helicobacter felis infection. BAC transgenic
mGAS-EGFP reporter mice, GAS-KO mice (19), and human progastrin-overexpressing (hGAS) transgenic mice (43) were maintained in
individual sterile microisolator cages under specific pathogen-free
housing conditions. All studies were performed with the approval of
the Institutional Animal Care and Use Committee at Columbia University Medical Center, accredited by the Association for Assessment
and Accreditation of Laboratory Animal Care. Helicobacter felis was
cultured and administered as previously described (36, 42). Briefly,
mice were infected by oral gavage with H. felis in 0.2 ml trypticase
broth three times per week on every other day for a total dose of 100
million colony-forming units per mouse. H. felis-uninfected mice
were sham dosed with 0.2 ml of broth. Mice were euthanized and
analyzed at 6 or 32 wk postinfection.

G335

Drugs and experimental design. The proton pump inhibitor omeprazole (Sigma, MO) was dissolved in a 1:1 mixture of DMSO
(Sigma) and polyethylene glycol (PEG) 300 (Fisher Scientific) at the
concentration of 40 mg/ml, and injected intraperitoneally 6 days per
week for 2 wk at the dose of 2 mg/mouse (⫽180 mol/kg). The
CCK2/gastrin receptor antagonist YF476 was a kind gift of Dr. Keiji
Miyata and Dr. Hidenobu Yuki (Astellas Pharma, Tokyo, Japan). The
drug was dissolved in PEG 300 at the concentration of 12 mg/ml and
subcutaneously injected twice per week for 2 wk at the dose of 20
mg/kg (⫽40 mol/kg) (42). Administration of octreotide (Bachem,
Torrance, CA) was performed in the following way: Alzet microosmotic pumps (model 1007D, Durect) were inserted into the center of
the back of animals after anesthesia with 2% isoflurane and oxygen
inhalation, and the skin incisions were closed with staples. The pumps
delivered PBS or octreotide at a rate of 3 g·kg⫺1·h⫺1 (1.8 g per
mouse per day of peptide) for 14 days before euthanasia.
Tissue preparation for histopathology and immunohistochemistry.
GFP was detected by direct fluorescent observation of frozen slides or
immunohistochemistry of paraffin slides with anti-GFP antibodies
(see below) according to previously published protocols. Briefly,
longitudinal sections of the stomach or other organs were fixed in 4%
paraformaldehyde (USB) or 10% buffered formalin (VWR International) solutions for 4 –16 h (depending on tissue size). To make
frozen sections, tissues were soaked in 30% sucrose (Fisher Scientific)
overnight, then embedded in TissueTek OCT compound (Sakura
Finetek) and prepared into 10-m sections. To make paraffin sections,
tissues were soaked in 70% ethanol, then processed and embedded in
paraffin and prepared into 5-m sections. The slides were deparaffinized, blocked with 3% peroxidase, and heated to 100°C in 0.01 M
sodium citrate buffer for antigen retrieval, and nonspecific antigenic
sites were blocked with 5% serum containing PBS for 30 min. The
slides were incubated for 1 h at room temperature or overnight at 4°C
with following primary antibodies: rabbit anti-GFP antibody (1:500
dilution, Invitrogen) or chicken anti-GFP antibody (1:500, Aves
Labs), goat anti-gastrin C-20 antibody (1:100, Santa Cruz), and rat
anti-EpCAM antibody (1:100, Iowa State University Hybridoma Facility), then appropriate secondary antibodies conjugated with Texas
red for frozen section or conjugated with horseradish peroxidase
(1:200, Vector Laboratories) for paraffin section were used. Frozen
sections were counterstained with 4=,6-diamidino-2-phenylindole
(DAPI; 2 g/ml, Sigma), and paraffin sections were counterstained
with hematoxylin solution (Fisher Scientific). The number of GFPpositive cells was expressed as the average number of positive cells
counted per ⫻300 magnification high-power field (5 fields per slide).
Stomach sections from genotype-negative littermates were used as
negative controls.
Administration with AOM and DSS. hGAS mice had the accelerated development of colonic tumors by administration with
azoxymethane (AOM) and dextran sodium sulfate (DSS) as previously described (26, 33). Therefore, hGAS/mGAS-EGFP doublemutant mice were injected once intraperitoneally with AOM of the
concentration of 12.5 mg/kg, and 1 wk later, mice were administrated
with DSS of the concentration of 2.5% in the drinking water for 1 wk.
Three weeks later, 2.5% DSS water was administrated again for 1 wk,
and mice were analyzed 4 mo after AOM injection.
Quantitative RT-PCR analysis. cDNAs were reverse transcribed
from 4 g of total RNAs obtained from mouse tissues using an
oligo(dT) primer according to the manufacturer’s protocol of Superscript III cDNA synthesis kit (Invitrogen). To confirm the integrity of
the RNA prepared, the cDNAs were also subjected to PCR amplification of GAPDH. The primer sequences are as follows: mouse
gastrin: forward 5=-catcatctggaccagggaccaa-3=, reverse 5=-cctccattcgtggcctctgct-3=; GFP: forward 5=-aagttcatctgcaccaccg-3=, reverse 5=tccttgaagaagatggtgcg-3=; GAPDH: forward 5=-gacatcaagaaggtggtgaagcag-3=, reverse 5=-ataccaggaaatgagcttgacaaa-3=. PCR amplification was performed in a total volume of 20 l by use of a QuantiTect
SYBR Green PCR kit (Qiagen). PCR amplification was performed by
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7300 real-time PCR system (Applied Biosystems) under the following
conditions: 94°C for 15 min, followed by 40 cycles at 94°C for 10 s,
55°C for 20 s, and 72°C for 30 s, then 1 cycle of 72°C for 10 min. The
expression level of each gene was normalized to the expression level
of internal control GAPDH by the ⌬⌬Ct method as previously
described (36, 37).
Evaluation of H. felis colonization by quantitative real-time PCR.
Small pieces (1–2 mm2) of tissue from the gastric antrum were digested
with proteinase K at 55°C for 24 – 48 h, followed by genomic DNA
extraction by use of a DNA isolation kit (Lamda Biotech) based on the
manufacturer’s instruction. H. felis colonization levels in gastric tissue
were quantified by real-time PCR assay with H. felis flagellar filament B
(flaB) primers using QuantiTect SYBR Green PCR kit (QIAGEN) and
7300 real-time PCR system (Applied Biosystems) as previously described (36, 37). The number of genomic copies of H. felis colonies was
normalized by comparison to GAPDH level determined by quantitative
PCR (qPCR), which was assumed to represent endogenous stomach
genomic DNA quantity. Primer sequences used in this experiment as
follows: H. felis flaB: forward; 5=-ttcgattggtcctacaggctcaga-3=, reverse;
5=-ttcttgttgatgacattgaccaacgca-3=, mouse GAPDH: 5=-gacatcaagaaggtggtgaagcag-3=, reverse; 5=-ataccaggaaatgagcttgacaaa-3=. PCR conditions are
95°C for 15 min followed by 40 cycles of 94°C for 10 s, 55°C for 20 s,
and 72°C for 30 s. Any sample detecting ⬍10 copies of the H. felis
genome was considered negative for H. felis colonization.
Measurement of serum amidated gastrin levels. Mouse serum was
collected by bleeding from incised brachial artery on anesthetized
mice into microcontainer serum separator tube (Becton Dickinson),
followed by centrifugation of 5 min at 6,000 rpm. Separated serum
was stored in ⫺80°C until usage. Amidated gastrin levels were
measured with antiserum 1296 as previously described (8, 15).
Statistical analysis. Statistical analysis by Student’s t-test was
performed by using Microsoft Excel, with significance at P ⬍ 0.01 or
0.05.
RESULTS

Generation and characterization of mGAS-EGFP-BAC
transgene. We and other groups have previously reported the
mouse gastrin gene structure, which consists of three short
exons with the length of 53, 216, and 192 base pairs (bp),
respectively, whereas the two introns contain 2,020 and 112
bp, respectively (Fig. 1A) (12, 20). By searching for BAC clone
DNAs that contained the entire mouse gastrin gene through the
Ensemble 129S7-derived mouse genomic BAC database, we
found two suitable clones. One of them, BAC clone bMQ262F1, was subsequently obtained from Genome Research Limited, the Wellcome Trust Sanger Institute (Cambridge, UK).
The open reading frame of mouse gastrin gene, located in the
second and third exons, was then replaced following the ATG
start codon with the EGFP cDNA-PGK-neomycin cassette by
the recombineering-base cloning strategy (9). To generate the
final transgene construct, PGK-neomycin cassette was removed by arabinose-induced Flpe recombinase gene (Fig. 1A).
BAC transgenic mGAS-EGFP reporter mice demonstrate
antral G cell-specific expression. Three potential founder lines
were identified. We analyzed the stomachs of F1 offspring
born from each of the three potential founders. As shown in
Fig. 1B, we detected GFP-positive cells at the base of the
gastric antrum, whereas there were few GFP-positive cells in
the transitional zone and no positive cells were detected in the
gastric corpus in all of the mice examined. To confirm that
these GFP-positive cells were truly G cells, we performed
fluorescence immunostaining with a gastrin antibody (goat
polyclonal, Santa Cruz). Most of the GFP-positive cells were

also positive for gastrin immunostaining, which confirmed that
these cells were indeed G cells (Fig. 1, C and D). On the basis
of these data, all three lines were then backcrossed to C57BL/
6NTac mice, and F2 to F5 generations were used in this study.
Acid suppression upregulates mGAS-EGFP transgene
expression. It is well established that suppression of acid
secretion from parietal (3, 30) cells results in physiological
stimulation of gastrin secretion and increased gastrin gene
expression. However, whereas a number of previous studies
have demonstrated increased gastrin mRNA abundance, it has
not been determined whether this upregulation was a result of
increased promoter activity and transcription, as opposed to
increased mRNA stability. Thus a reporter gene that contained
the murine gastrin promoter upstream of a reporter gene, such
as EGFP, offers the ideal tool for addressing this question.
Consequently, we administered two types of acid-suppressive
drugs: the proton pump inhibitor omeprazole and the gastrin/
CCK2 receptor antagonist YF476. As shown in Fig. 2, administration of either omeprazole or YF476 for 2 wk increased the
intensity of GFP signals as well as the number of GFP(⫹) cells
in the gastric antrum of the mGAS-EGFP mice. Interestingly,
the increase in the number of GFP-expressing cells induced by
omeprazole was greater than that induced by YF476. In addition, as shown in Fig. 3A, we confirmed that these treatments
resulted in an increase of GFP mRNA as well as gastrin mRNA
expression by quantitative real-time reverse transcription-PCR
(qRT-PCR). Furthermore, we confirmed through gastrin immunoassay of serum samples that hypergastrinemia was indeed
induced by these acid-suppressive reagents (Fig. 3B). Taken
together, these data demonstrate that acid-suppressive regimens resulted in upregulation of murine gastrin promoter
activity and transcription.
Fasting, somatostatin infusion, and Helicobacter felis infection suppressed mGAS-EGFP transgene expression. Next, we
examined the possible suppression of gastrin promoter activity
using several regimens that have been reported to downregulate gastrin gene expression in vivo, including overnight fasting (44), systemic infusion of octreotide (a long-lasting analog
of somatostatin) (45), and H. felis infection (14, 37). As shown
in Fig. 4, we confirmed that the intensity of GFP signals was
significantly decreased in these three conditions (Fig. 4, A–C)
compared with the untreated, fed control (Fig. 4D). Moreover,
the overall number of GFP(⫹) cells was decreased with the
three treatments compared with the control (Fig. 4E). In addition, downregulation of the level of GFP mRNA in these
experiments was also examined by qRT-PCR. Overall, the
gastrin promoter and GFP mRNA was clearly suppressed in
parallel with endogenous gastrin gene expression by fasting,
consistent with transcriptional regulation (Fig. 5A), but not
significantly repressed by octreotide or H. felis infection. Serum gastrin levels were markedly reduced in the mice by
fasting, whereas octreotide treatment and H. felis infection did
not result in a significant change of serum gastrin levels (Fig.
5B) despite successful H. felis colonization in the stomach, as
confirmed by qPCR (Fig. 5C) and hematoxylin-eosin histology
(data not shown).
Increased GFP expression in the antrum of gastrin-deficient
mice. We and other group have previously reported that gastrin
deficiency altered gastric mucosal differentiation and homeostasis (13, 19). However, so far no data have been described about the status of transcriptional machinery for gastrin
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Fig. 1. Characterization of the mouse gastrin gene and the
transgene construct of bacterial artificial chromosome (BAC)
transgenic murine gastrin-promoter enhanced green fluorescent
protein (EGFP) reporter (mGAS-EGFP) mice and the expression of green fluorescent protein (GFP) signals in the antrum
and the transitional zone of mGAS-EGFP mice. A: genomic
segment encompassing the mouse gastrin gene locus is represented as a horizontal line. Exons are represented as filled boxes
and introns are unshaded. The transgene construct of mGASEGFP mice is created by replacing the open reading frame of the
mouse gastrin gene, located in the 2nd and 3rd exons, after the
ATG start codon with the EGFP cDNA-SV40polyA-PGKneomycin cassette by using the BAC recombineering technology, followed by the removal of PGK-neomycin cassette with
arabinose-induced Flpe recombinase gene. B: GFP expression in the gastric antrum and corpus of mGAS-EGFP
mice. Left: merged image of GFP signals and 4=,6-diamidino-2-phenylindole (DAPI) staining in the gastric antrum (magnification: ⫻400). Right: merged image of GFP
signals and DAPI staining from the gastric corpus to the
transitional zone (magnification: ⫻200). Many GFP-positive cells were detected in the gastric antrum, whereas
there were few positive cells in the transitional zone and
no positive cells in the corpus. C: immunohistochemical
staining with anti-amidated gastrin antibody in the antrum.
Anti-amidated gastrin immunostaining with Texas red
(left) and merged image of GFP expression with antiamidated gastrin immunostaining (right) (magnification:
⫻400). D: bright-field immunohistochemical staining with
anti-GFP and anti-amidated gastrin antibodies in the antrum. Anti-GFP antibody immunostaining (left) and antiamidated gastrin antibody immunostaining (right), both
followed by peroxidase-conjugated secondary antibodies
and diaminobenzidine staining (magnification: ⫻200). C
and D: images indicated that most of the GFP-positive
cells were also positive for gastrin immunostaining, which
confirmed that these cells were indeed G cells.

gene expression in the setting of gastrin deficiency. Thus, to
further investigate, we next crossed mGAS-EGFP mice with
GAS-KO mice to determine whether gastrin deficiency resulted in any changes for gastrin gene transcription. As shown
in Fig. 6, A–C, the number of GFP(⫹) cells in the gastric
antrum were significantly increased in homozygous GASKO/mGAS-EGFP double-mutant mice compared with heterozygous GAS-KO/mGAS-EGFP double-mutant or
mGAS-EGFP single-transgenic mice. These results indicate
that gastrin deficiency is able to stimulate gastrin transcription and that gastrin gene regulation is indeed regulated in
vivo.
Developmental and tissue-specific regulation of the transgene in mGAS-EGFP mice. In addition to physiological regulation, we sought to determine whether the transgene expression of mGAS-EGFP mice was correctly regulated in both a
developmental- and tissue-specific manner. A number of pre-

vious reports had shown that the gastrin gene is upregulated in
late fetal development, primarily in the pancreatic islets (2). As
shown in Fig. 7, A and B, we observed a few GFP weakly
positive cells in the pancreatic islets and the small intestinal
villi of the transgenic murine fetus at 18.5 days postconception
(dpc). We employed immunostaining with an anti-GFP antibody for these studies of the fetal pancreas and small intestine,
primarily because the intensity of the GFP signal was too weak
to be evident under direct fluorescence. Of note, these GFP
signals disappeared in these organs at ⬃2 days after birth,
indicating appropriate developmental regulation. We detected
the appearance of GFP(⫹) cells in the gastric antrum at 2 days
after birth, but no GFP signals were detected in this location at
the fetal stage (data not shown). As shown in Fig. 7C, some of
GFP(⫹) cells in the neonatal antrum were located not at the
base of the antral glands but higher up in the middle to the top
third of the glands.
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Fig. 2. Increased intensity of GFP signals
and GFP-positive cell numbers in the gastric
antrum of mGAS-EGFP mice after administration of acid-suppressive reagents. A–
C: merged images of GFP expression with
DAPI staining in the antrum of mGASEGFP mice (magnification: ⫻600). A: mice
were injected intraperitoneally with omeprazole (OMP; 5 days per week) for 2 wk.
B: mice were injected intraperitoneally with
gastrin/CCK2 receptor antagonist YF476
(twice per week) for 2 wk. C: mice were
injected intraperitoneally with vehicle only
for 2 wk. D: total numbers of GFP-positive
cells in the antrum of mGAS-EGFP mice by
administration with OMP or YF476 or vehicle only. The number of GFP-positive cells
was expressed as the average number of
positive cells counted per ⫻300 magnification high-power field. From each slide, cells
were counted from at least 5 fields, and 3
slides (⫽3 mice) from each group were analyzed. The administration of either OMP or
YF476 for 2 wk increased the intensity of
GFP signals as well as the number of GFP(⫹)
cells in the gastric antrum of the mGAS-EGFP
mice. *P ⬍ 0.05, **P ⬍ 0.01; n ⫽ 3 for each
group.

Studies in the past that have relied primarily on radioimmunoassay of tissue extracts have reported gastrin expression in the
organs other than stomach, such as pituitary gland, brain, testis,
and ovary (11, 12, 27, 29). Therefore, we investigated the possible
presence of GFP expression in these tissues. As shown in Fig. 8A,
weak GFP signals could be detected in the anterior lobe of the

pituitary gland, and immunofluorescence staining with anti-amidated gastrin antibody or immunohistochemistry with anti-GFP
antibody confirmed both endogenous gastrin as well as EGFP
expression in this tissue (Fig. 8, B and C). In contrast, we were
unable to detect GFP signals or endogenous gastrin expression in
the cerebral cortex, testis, or ovary (data not shown).

Fig. 3. Quantitative real-time RT-PCR analysis
of GFP and gastrin expression in the stomachs
of mGAS-EGFP mice and serum gastrin levels
after administration of acid-suppressive reagents. A: GFP and gastrin expression were
analyzed by quantitative real-time RT-PCR
(qRT-PCR) in the stomachs of mGAS-EGFP
mice administered with either OMP (5 days per
week) or YF476 (twice per week) or vehicle
only for 2 wk; n ⫽ 3 for each group. Both GFP
and gastrin expression in the stomachs of
mGAS-EGFP mice treated with either OMP or
YF476 were significantly higher than in mice
treated with vehicle only. *P ⬍ 0.05, **P ⬍
0.01; n ⫽ 3 for each group. B: total amidated
gastrin levels were measured in serum from
mGAS-EGFP mice administered with either
OMP (5 days per week) or YF476 (twice per
week) or vehicle only for 2 wk; n ⫽ 3 for each
group. Hypergastrinemia was induced by these
acid-suppressive reagents, especially OMP
treatment resulted in significantly higher serum
gastrin levels compared with vehicle only.
*P ⬍ 0.05; n ⫽ 3 for each group.
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Fig. 4. Decreased GFP signal intensity and
GFP-positive cell numbers in the gastric antrum of mGAS-EGFP mice following administration of somatostatin, overnight fasting, and
Helicobacter felis infection. A–D: merged image of GFP expression with DAPI staining in
the antrum of mGAS-EGFP mice (magnification: ⫻600). A: mice were systemically infused
with octreotide (long-lasting somatostatin ortholog) for 2 wk by use of osmotic minipumps.
B: mice were fasted overnight. C: mice were
infected with H. felis for 6 wk. D: mice without
treatment (wt) or infection. E: total numbers of
GFP-positive cells in the antrum of mGASEGFP mice by systemic infusion with the somatostatin ortholog octreotide (SST) for 2 wk,
overnight fasting, and H. felis infection for 6
wk. The number of GFP-positive cells were
expressed as the average number of positive
cells counted per ⫻300 magnification highpower field. From each slide, cells were
counted from at least 5 fields, and 3 slides (⫽3
mice) from each group were analyzed. The
systemic infusion with somatostatin for 2 wk
or overnight fasting or H. felis infection for 6
wk decreased the intensity of GFP signals as
well as the number of GFP(⫹) cells in the
gastric antrum of the mGAS-EGFP mice.
*P ⬍ 0.05, **P ⬍ 0.01; n ⫽ 3 for each group.

GFP-positive cells in the colonic tumors induced by administration of AOM and DSS. Next we analyzed GFP expression
in a mouse model of colon cancer induced by administration
with AOM and/or DSS in hGAS mice crossed to mGAS-EGFP
mice. We chose to conduct this study in hGAS background
because we previously found that hGAS mice had the more
rapid and more advanced tumors by AOM and/or DSS treatment (33). As shown in Fig. 9A, we successfully obtained
colonic tumors in the distal colon and the rectum of hGAS/
mGAS-EGFP mice at ⬃16 wk after initial treatment with
AOM/DSS protocol (26). GFP-positive cells were detected in
these colon tumors (Fig. 9B). We also performed fluorescence
immunostaining with anti-EpCAM antibody, and we observed
most of GFP(⫹) cells in the tumors were EpCAM positive; i.e.,
these cells were epithelial cancer cells (Fig. 9B). Furthermore,
we performed immunostaining with anti-GFP antibody, and we
observed most of GFP(⫹) cells were detected in the neoplastic
glands (Fig. 9C). Finally, we performed immunostaining with

anti-amidated gastrin antibody, and none of GFP(⫹) cells were
positive, suggesting that these cells expressed nonamidated
form of gastrin (data not shown).
DISCUSSION

In this study, we have generated EGFP reporter mice under
the entire murine gastrin promoter by BAC transgenic technology. All three founders showed strong GFP expression in the
gastric antrum as well as the transitional zone to the corpus. In
addition, GFP(⫹) cells could be detected in the pancreatic
islets and the small intestinal villi of the fetus, but not in these
organs of the adult mice. These results indicate that the transgene was expressed in an appropriate developmental and tissue-specific manner. However, importantly, the transgene was
regulated in a correct physiology and pathophysiological manner, with increases in the stomach with acid suppression and
decreases with fasting and octreotide, showing for the first time
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Fig. 5. Quantitative real-time RT-PCR analysis
of GFP and gastrin expression in the stomachs
of mGAS-EGFP mice and serum gastrin levels
after systemic infusion of octreotide, overnight
fasting, and Helicobacter felis infection.
A: GFP and gastrin mRNA expression were
analyzed by quantitative real-time RT-PCR in
the stomachs of mGAS-EGFP mice after systemic infusion of octreotide, long-lasting somatostatin (SST) homolog, for 2 wk or overnight
fasting or Helicobacter felis infection for 6 wk;
n ⫽ 3 for each group. Both of GFP and gastrin
expression in the stomachs of mGAS-EGFP
mice after these treatments showed lower expression level, especially overnight fasting resulted in significantly lower expression compared with mice without treatment. *P ⬍ 0.05;
n ⫽ 3 for each group. B: total amidated gastrin
levels were measured in serum from mGASEGFP mice after systemic infusion of octreotide for 2 wk or overnight fasting or H. felis
infection for 6 wk; n ⫽ 3 for each group.
Hypogastrinemia was induced by octreotide
infusion or overnight fasting, especially overnight fasting resulted in significantly lower serum gastrin levels compared with vehicle only,
whereas H. felis infection did not change serum
gastrin levels. *P ⬍ 0.05; n ⫽ 3 for each group.
C: H. felis colonization in the stomachs of H.
felis-infected mGAS-EGFP transgenic mice at
6 and 32 wk (6w and 32w) postinfection as
measured by quantitative real-time PCR of
genomic DNAs; n ⫽ 3 for each group. DNA
copy numbers of H. felis normalized to
GAPDH (per 100,000 copies) in the stomachs
were approximately the same among the 2 time
points. Of note, no H. felis DNAs were detected
in the stomachs of mGAS-EGFP mice without
infection.

that such regulation is likely transcriptional. Finally, studies
with the AOM/DSS model of colonic neoplasia show upregulation in a small subset of colonic epithelial cells, in the
absence of expression of amidated gastrin, confirming previous
reports that the gastrin gene is activated at early stages of
colonic carcinogenesis.
Our data point to the inherent advantages of the use of BAC
transgenic technology in view of the lower rate of success the
traditional plasmid-based transgenic technology (40) and lack
of ideal cell-specific expression with most of our previous
gastrin promoter constructs (24, 41, 43, 46). Of note, we
performed qPCR to evaluate the copy numbers of BAC transgenic construct in each line of mGAS-EGFP mice using tail
DNAs, and we found that all three founders had one copy of
the transgene integrated into their genome (data not shown).
These data indicated one copy of the EGFP transgene in the
mouse genome was enough for the analysis of tissue-specific
EGFP expression as previously described (22).
The main site of gastrin expression in rodents is in the distal
stomach, and our mGAS-EGFP transgenic mice showed appropriate GFP expression in the gastric antral G cells, a finding
confirmed by fluorescence immunostaining with an anti-gastrin
antibody. It should be noted, though, that some GFP(⫹) cells
were completely negative for gastrin immunostaining. One

possible reason for this discrepancy is that these GFP(⫹) cells
in the gastric antrum might produce only nonamidated forms of
gastrin, since the antibody used in this study was specific to
amidated gastrin. However, immunofluorescent staining of the
gastric antrum with antibodies specific for human progastrin
and glycine-extended gastrin was unsuccessful (data not
shown), which could be due to specific differences or the very
low level of peptides in these cells. Another possibility is that
the translation of gastrin mRNA might be suppressed in these
cells by the novel mechanism such as noncoding RNAs as was
recently reported in other endocrine cells (10, 31).
It has been well described that an increase in gastric pH by
pharmacological or physiological conditions regulates gastrin
gene expression (11, 30). We confirmed that the intensity of
GFP(⫹) signals and also the number of GFP(⫹) cells were
significantly increased in the gastric antrum by administration
with proton pump inhibitor omeprazole or gastrin/CCK2 receptor antagonist YF476. These data were compatible with our
previous finding that treatment with either of omeprazole or
YF476 of human amidated-gastrin-overexpressing transgenic
(INS-GAS) mice significantly increased serum gastrin levels
(36). In contrast, we found that overnight fasting led to the
significant decreases in the intensity of GFP signals and
GFP(⫹) cell numbers, which was consistent with previous
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reports (44). In addition, the systemic infusion of octreotide, a
long-lasting analog of somatostatin, showed a tendency (that
was not statistically significant) toward suppression of GFP
signal intensity as well as GFP(⫹) cell numbers (45). Thus
regulation of the mGAS-EGFP BAC transgene reproduced the

Fig. 6. Increase in the intensity of GFP signals and GFP-positive cell numbers in
the gastric antrum of gastrin-deficient (GAS-KO)/mGAS-EGFP double-mutant
mice. A: merged image of GFP expression with DAPI staining in the antrum of
homozygous GAS-KO/mGAS-EGFP double-mutant mice. B: merged image of
GFP expression with DAPI staining in the antrum of heterozygous GAS-KO/
mGAS-EGFP double-mutant mice (magnification for A and B: ⫻400). C: total
numbers of GFP-positive cells in the antrum of homozygous (GAS⫺/⫺) and
heterozygous (GAS⫹/⫺) GAS-KO/mGAS-EGFP double-mutant mice and
mGAS-EGFP single-transgenic mice (GAS⫹/⫹). The number of GFP-positive
cells were expressed as the average number of positive cells counted per ⫻300
magnification high-power field. From each slide, cells were counted from at least
5 fields, and 3 slides (⫽3 mice) from each group were analyzed. GFP(⫹) cell
numbers in the gastric antrum were significantly increased in homozygous GASKO/mGAS-EGFP double-mutant mice compared with heterozygous GAS-KO/
mGAS-EGFP double-mutant or mGAS-EGFP single-transgenic mice. **P ⬍
0.01; n ⫽ 3 for each group.

Fig. 7. GFP expression in the fetal and neonatal organs of mGAS-EGFP mice.
A and B: immunohistochemical staining with anti-GFP antibody in the fetal
pancreas (A) and small intestinal villi (B) of mGAS-EGFP mice at 18.5 days
postconception (dpc). C: merged image of GFP expression with DAPI staining
in the gastric antrum of neonatal mGAS-EGFP mice at 2 days after birth
(magnification for A–C: ⫻200; scale bar for A and B: 50 m). GFP(⫹) cells
were detected in the pancreatic islets and the small intestinal villi of the fetus
of mGAS-EGFP mice at 18.5 dpc, whereas GFP(⫹) cells appeared in the
gastric antrum of neonatal mGAS-EGFP mice at 2 days after birth. Of note,
GFP(⫹) cells in the neonatal antrum were located at not only the base of the
antral glands but also higher up in the middle to the top third of the glands.
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Previous papers reported that the numbers of G cells and D
cells in the stomachs of H. pylori-infected patients both
showed significant decreases compared with those in noninfected healthy subjects, whereas a significant increase of Gto-D cell ratio could explain the hypergastrinemia observed in
H. pylori-infected duodenal ulcer patients (14, 16). In the
present study, H. felis infection of mGAS-EGFP mice resulted
in a significant decrease in GFP signal intensity as well as

Fig. 8. GFP expression in the anterior lobe of the pituitary gland of mGASEGFP mice. A: GFP expression in the anterior lobe of the pituitary gland of
mGAS-EGFP mice. B: immunofluorescence staining with anti-amidated gastrin antibody followed by Texas red-conjugated anti-goat secondary antibody
in the same slides as A (magnification for A–B: ⫻100). C: immunohistochemistry with anti-GFP antibody in the anterior lobe of the pituitary gland of
mGAS-EGFP mice (scale bar: 50 m, magnification: ⫻300). Weak GFP
signals were observed in the anterior lobe of the pituitary gland of mGASEGFP mice, and immunofluorescence staining with anti-amidated gastrin
antibody confirmed that these GFP-positive cells in the anterior lobe of the
pituitary gland were also positive for amidated gastrin.

patterns of endogenous gastrin gene expression, pointing to a
mechanism of transcriptional regulation.
H. pylori infection has also been reported to regulate gastrin
gene expression as well as G cell numbers in the antrum.

Fig. 9. GFP expression in the cancer cells of the colon tumors induced by
administration with azoxymethane (AOM) and dextran sodium sulfate (DSS)
in hyperprogastrinemic hGAS/mGAS-EGFP double-transgenic mice. A: macroimage of the colorectal tumors of hGAS/mGAS-EGFP double-transgenic
mice after 4 mo of administration with AOM and DSS (scale bar: 5 mm).
B: merged image of GFP expression with fluorescence immunostaining with
anti-EpCAM antibody followed by Texas red-conjugated anti-rat secondary
antibody in the colorectal tumors of hGAS/mGAS-EGFP mice after 4 mo of
administration with AOM and DSS (magnification: ⫻600). C: immunohistochemistry with anti-GFP antibody in the colon tumors of hGAS/mGAS-EGFP
mice after 4 mo of administration with AOM and DSS (scale bar: 50 m,
magnification: ⫻200). Most of the GFP(⫹) cells were detected in the neoplastic colonic glands, and they were EpCAM positive, which indicated they were
epithelial cancer cells.
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GFP(⫹) cells numbers (Fig. 4, C and E), which were consistent
with the (insignificant) trend toward a suppression of GFP and
gastrin gene expression (Fig. 5A), although these findings were
not consistent with the serum gastrin levels of mGAS-EGFP
mice infected with H. felis for 6 wk (Fig. 5B). This discrepancy
might reflect differing mechanisms for the regulation of transcription, secretion, or G cell number. We also analyzed gastrin
transcriptional changes in gastrin deficiency using GAS-KO/
mGAS-EGFP double-mutant mice and found that the GFP
signal intensity as well as GFP-positive cell numbers in the
gastric antrum were significantly increased. Taken together,
these data indicate that the gastrin transcriptional machinery is
activated by gastrin deficiency in vivo, and that gastrin may
therefore repress its own transcription. It seems likely that the
upregulation of gastrin gene expression by gastrin deficiency
might occur through an indirect mechanism, which might
include a decrease in gastric acid output and/or an increase in
gastric pH, both of which might have stimulated gastrin gene
description (19).
Gastrin has been reported to be expressed not only in the
antrum but other organs such as the duodenum, pancreas,
brain, pituitary glands, testis, and ovary in variety of species
(11, 12, 27, 29). In this study, we detected weak GFP signals
in the anterior lobe of the pituitary gland, but not in the other
organs such as duodenum, pancreas, testis, or ovary of the
adult mouse. Instead, we observed rare GFP-positive cells in
the small intestinal epithelium as well as in the pancreatic islet
cells of the fetus (18.5 dpc). Mensah-Osman et al. (23) recently
reported that in their hGasBAC/GAS-KO double-mutant mice,
they observed human gastrin expression in adult duodenum,
whereas they confirmed that no gastrin was expressed in adult
mouse duodenum. These data point to important speciesspecific differences in the tissue-specific regulation of gastrin
gene expression.
Finally we analyzed GFP expression in colonic tumors
induced by administration of AOM and/or DSS. We found
GFP(⫹) cells in tumors of the distal colon as well as the
rectum, but not in the nontumorous proximal colon, and most
of these GFP⫹ cells were detected in the colonic neoplastic
glands. The human gastrin gene is a known downstream target
of oncogenic signals such as mutant K-Ras, Wnt/␤-catenin,
and TGF-␤/Smad, and its expression is consistently upregulated in the colon cancer cells (6, 17, 21, 25). Furthermore, we
have previously reported that gastrin deficiency in ApcMin
mice significantly reduced the size and numbers of intestinal
polyps (19). Therefore, we would speculate that the presence of
GFP(⫹) cells points to the upregulation of gastrin gene expression in a subset of colonic tumor cells. Whether these cells
represent partially differentiated tumor cells or cancer stem
cells will require further investigation.
In conclusion, the mGAS-EGFP BAC transgene showed
expression of GFP signals in G cells of the gastric antrum as
well as the fetal pancreatic islets and small intestinal villi and
was regulated in a correct physiological manner, pointing to
the importance of transcriptional control in the achievement of
developmental and tissue-specific regulation. Furthermore, we
identified GFP(⫹) cells in the anterior lobe of pituitary glands
and the colonic cancer cells induced by AOM and/or DSS
treatment. Although the precise characterization of these
GFP(⫹) cells in the setting of cancer will require additional
work, in view of the complicated posttranslation processing of

G343

gastrin gene product, these mice may provide a useful opportunity to study the regulation of mouse gastrin gene in vivo and
may contribute to our understanding of the mechanisms involved in transcriptional control of this gene.
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